Comparison of Buprenorphine and Methadone - 3

National Institutes of Health (NIH)

Status and phase: Completed; Phase 2

Conditions: Opioid-Related Disorders

Treatments: Drug: Buprenorphine

Study type: Interventional

Funder types: Other U.S. Federal agency; NIH

Identifiers

NCT00000334

Y01-3-0009-3

NIDA-3-0009-3

Details and patient eligibility

About

The purpose of this study is to compare agonist and antagonist profile associated with buprenorphine vs. methadone during opiate withdrawal.

Sex: Male

Ages: 23 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.